Building Resilience into the Nation's Medical Product Supply Chains (2022) / Chapter Skim
Currently Skimming:
7 Mitigation Measures for Resilient Medical Product Supply Chains
7 Mitigation Measures for Resilient Medical Product Supply Chains
Pages 183-196
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 183... ...
Routine shortages ultimately affect the health care system's ability to function effectively during both routine operations and public health emergencies. Making medical product supply chains more resilient during routine conditions will make them more resilient during public health emergencies.
|
From page 184... ...
. Therefore, the interests of medical product suppliers and manufacturers, which align with maximizing profits and minimizing costs, can lead to insufficient supply and inadequate quality of medical products causing supply shortages (NASEM, 2018b)
|
From page 185... ...
To mitigate routine medical product shortages and their effect on clinical care, manufacturers, suppliers, and health systems must improve existing processes throughout medical product supply chains. This hardening of medical product supply chains requires that manufacturers reliably produce quality medical products, and that health systems purchase these higher quality products for the patients they serve.
|
From page 186... ...
. Implementing a Drug-Quality Rating System The FDA Drug Shortages Task Force recommended the implementation of a quality rating system to introduce greater transparency into the quality management systems behind the drugs that consumers purchase (FDA Drug Shortages Task Force, 2020)
|
From page 187... ...
.2 In providing this transparency, the market will adapt to reward facilities that have a more mature quality system than their competitors. In the absence of the quality rating system that the Drug Shortages Task Force recommends as an enduring solution to drug shortages, health systems can put pressure on suppliers to share more information on the quality of a product.
|
From page 188... ...
can provide manufacturers a competitive edge by improving efficiencies, especially for manufacturers of generic products. Using QbD concepts also promotes flexibility in sourcing material and the overall adaptability of supply chains (Crowley and McCrossen, 2016)
|
From page 189... ...
DIVERSIFICATION OF MEDICAL PRODUCT SUPPLY CHAINS The consolidation and geographic concentration of raw material suppliers in medical product supply chains poses risks to the ability of manufacturers further down the supply chain to secure basic supplies to make their own products (NASEM, 2018a)
|
From page 190... ...
Active pharmaceutical ingredient (API) and raw material suppliers, medical product manufacturers, GPOs and distributors, and health systems all have a responsibility to improve diversification across medical product supply chains.
|
From page 191... ...
Alternatively, health systems that use GPOs could demand that contracts ensure sourcing from a diverse array of suppliers for high-risk medical products. These purchasing strategies not only help to protect health systems from experiencing shortages when supply from one source is disrupted, but promote competition between medical product manufacturers to provide a more reliable supply.
|
From page 192... ...
This type of contracting adds resilience to many areas of medical product supply chains. The manufacturer has an assured volume of purchases for an extended period of time, allowing investments in the quality of production.
|
From page 193... ...
. The subsequent recommendation builds on these reports, by tasking health systems with actions, that when taken together with manufacturers and suppliers, can build robust mitigation measures into medical product supply chains.
|
From page 194... ...
https:// consultqd.clevelandclinic.org/inpatient-pharmacy-leaders-lower-costs-dashboard-tool/ (accessed October 15, 2021)
|
From page 195... ...
. FDA Drug Shortages Task Force.
|
From page 196... ...
hospitals. In Vizient Drug Shortages Impact Report.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.